DOCSLIB.ORG

Title Company Program Manager Abengoa Bioenergia Nuevas

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Title Company Program Manager Abengoa Bioenergia Nuevas Title Company Program Manager Abengoa Bioenergia Nuevas Tecnologias Executive Vice President Abengoa Bioenergy Doctor (Ph.D) Abengoa Research Manager ABIQUIM CEO ACBC Atlantic Council for Bioenergy CEO ACIES BIO Advanced Renewables Developmen Acme-Hardesty New Business Development Manager ADM VP, Renewable Chemicals ADM Principal Advancebio Systems, LLC Advanced Biofuels USA Managing Director Advanced Enzyme Technologies Ltd CEO Aequor, Inc. MANAGING DIRECTOR AFGO INTERNATIONAL TRADING COMPANY LIMIT Segment Strategy Manager AGCO Corporation Chief Agriculture and Agrifood Canada Economist Agriculture Canada President & CEO Agrisoma Biosciences, Inc President, CTO Agrivida, Inc Director of Commercialization Ag-West Bio Inc. Associate Director, North America Ajinomoto Co., Inc. Chief Scientist Vice President AkzoNobel Director Business Development Alberici Vice President, Market Leader Alberici Senior Business Partner Alberta Innovates Technology Futures Executive Director Algae Biomass Organization Chief Scientific Officer Algenol Business Stream Leader - Proce Amec Foster Wheeler green chemsitry program manage Amerian Chemical Society CEO American Process, Inc. Vice President, Data Science Amyris, Inc. Founder, President & CEO Anellotech, Inc. Marketing Manager Applied Chemical Technology Senor Consultant Aquaculture Communications Group LLC. Exec President Arancia Industrial Chief Operating Officer Arbiom Director of Strategic Marketing Archer Daniels Midland Company Director/Strategic Integration Arizona State University CBO Arzeda President ASPVV VP - Global Policy ASTM Scientist ATB Potsdam Executive Director of BioNB Atlantic Canada Bio-Industries Alliance Managing Partner Aurora Equity Chairman Board Avantium Technology Development Manager Axens Executive Officer AZERTIKINTISERVIS 10 I.T.Q.I President Barber Advisors LLC Principal Barsher & Associates Head of New Business Development BASF Senior Vice President BASF SE Principal BASF Venture Capital Commercialization Manager Battelle, Pacific Northwest National Laboratory Dept Man., Oil, Gaz & Biofuels BBA Inc. Chief Executive Officer BBS NanoMedicina Zrt Director of Business Dev BC Bioenergy Network Chairman of Executive Board BE-Basic Foundation MA BE-Basic Foundation Associate Bereskin & Parr LLP Senior Chemist Bergeson & Campbell, P.C. Staff Scientist Berkeley Lab R&D Manager Bio Base Europe Pilot Plant Marketing Officer Bio Gas & Energy Development Company Biotech Sales Manager Bio Springer Manager- Memberships and Partnerships BioAlberta BioAmber Inc. Chief Commercial Officer BioAmber Inc. Vice Chairman Biobased Delta Managing director Biobased Delta Stakeholder relations Biobased Industries Consortium Executive Director Biobased Industries Consortium Technical Director Biocatalysts Ltd Head of Industrial Biotech BIOCERES President & CEO BioComposites Group Inc. Managing Partner Bioeconomy Partners, LLC Partner BioEngine Venture Capital Sales Manager Bioengineering, Inc. VP Technology BIOENTERPRISE Strategic Partnerships Manager Bioenterprise Corporation Strategist & Consultant BioFiber Solutions International, Inc. BD & TT Officer Biofuelnet Canada Government Affairs Officer Biofuelnet Canada Chairman Bioindustrial Innovation Canada Coordinator BioIndustrial Process Research Centre President BioIntelligence Technologies President Biolin Research Inc. CEO BIOMETHODES Ing, BIOMIN Holding Gmbh Business Development Officer BioNB Managing Director BioNova VP & Co-founder Biopolynet Scientific Extension Lead Biorefining Conversions Network CEO Biosynthetic Technologies President & CEO BIOTECanada President Bio-Technical Resources CEO Biotrend Partner Blakely Sokoloff Taylor & Zafman, LLP Market Consultant Blume Distillation Founder Boyden Gray & Associates PLLC Chief Bioscientist BP, plc Business Development Director BPF Coordinator of Innovation in Renewables Technologies BRASKEM S/A Head of the Chemicals Department Brazilian Development Bank (BNDES) Vice President-Industrial Calgon Carbon Corporation CTO Calysta Trade Commissioner Canadian Government Executive Co-Chair Canadian Prairie BioSciences Technology & Innovation Carboniq Inc. President and Plant Breeder CAREnergy, LLC Managing Director Cargill BIOasis VP, Fermentation Cargill, Inc Director Cathay Industrial Biotech, Ltd. Vice President Cathay Industrial Biotech, Ltd. Senior Scientist/Engineer Ceapro Inc. Business Development Cedar Rapids Metro Econ Alliance Director Celignis Head of Biotransformation CentraleSupelec Paris Director CEPROCQ Lead Process Engineer CH2M Hill Sr. Business Development CH2M HILL Engineers Inc. Project Leader Chalmers University of Technology Senior Researcher Changhae Ethanol Co., LTD. Director, Communications and Marketing Chemical Institute of Canada Vice President, CCO Chemistria Director, Business & Economics Chemistry Industry Association of Canada President & CEO Chief Executive Assistance, Inc BUSINESS DEVELOPMENT MANAGER CHIMEX Director, TechID, Chromatin, Inc Global Business Development Clariant Global Director Clariant Produkte (Deutschland) GmbH Managing Partner c-LEcta SVP, Process Engineering & CTO CO2 Solutions Inc. Professor Columbia University CTO and Founder Comet Biorefining Inc. President and CEO Composites Innovation Centre Manitoba Sr.V.P. Bioprocess Engineering CONAGEN VP, Project Management Concord Blue Energy, Inc. PhD Candidate Concordia University VP Corporate Development Conifex Timber Inc. Trade Commissioner Consulate General of Canada Honorary Consul in Iowa Consulate General of Canada CTO Corbion President Coup de Pouce ONGD Director of Projects and Strategic Initiatives CRB CEO CRIBE Senior Principle Reserch Scientist CSIRO Head of R&D Cellulosic Biofuel CTC Executive Director Cultivation Corridor Founder and Managing Partner Cycle Capital Management President Czar Salt Professor Dalhousie University Professor Dankook University Director Deloitte Trade Commissioner Dept of International Trade Canada President & CEO DINB Chief Commercial Officer DNA2.0 President Dodds & Associates LLC Manager, Ventures Dow Chemical Director Drystill Technologies President DSM Chief Technology Officer DSM Bio-Based Products & Services Senior Project Manager DSM Food Specialties Assistant Director Duke University DuPont Fellow DuPont Principal DWH Process Consulting Chief Operating Officer Dyadic International, Inc Chief Technology Officer Earth Energy Renewables, LLC VP Corporate Development Ecosynthetix Inc. Senior V.P. Business Development EDAgency CEO EDO STATE GOVERNMENT CTO EggPlant S.r.l. VP Corporate Development Elevance Renewable Sciences, Inc Deputy Head of Mission Embassy Kingdom of the Netherlands Trade Commissioner (Innovation, Science & Technology)Embassy of Canada In France Vice President Emerald Advisers, Inc Investment Director Emerald Technology Ventures President & CEO Enerkem Technology Development Enmex SA de CV CEO Enmex SA de CV Executive Vice President, Finance and Corporate DevelopmentEnsyn Corporation Chairman & CEO Ensyn Corporation Notification Specialist, Health Canada Environment Canada and Health Canada New Substances Program Environment Canada Biotechnology Section Scientific Officer European Commission - Directorate-General Joint Research Marketing Officer Everest Energy Development Co.(Pvt.) Ltd VP, Strategy & Public Affairs Evolva Innovation Fields Food & Care Evonik Creavis GmbH CEO Exigence Technologies VP, Business Development Exigence Technologies Inc. Sr. Research Chemist ExxonMobil Chemical Company Senir Vice President of R&D Far Eastern New Century Corporation Partner, Patent Agent Fasken Martineau DuMoulin LLP Researcher Federal University of Goias Co-President First Green Partners Partner Flagship Ventures Agricultural Attache Foreign Agricultural Service - USDA Director, Bus/Corp Development Forelight, LLC VP, Regulations & Partnerships Forest Products Association of Canada Timber Policy Adisor Forestry Commission Scotland VP Pulp, Paper & BioProducts FPInnovations Vice President of Business Development Fulcrum Bioenergy Market Manager GEA Canada Inc., Barr-Rosin division BDM Gene Bridges, Gmbh Technical Fellow General Motors CEO Genomatica, Inc CSO Genome Prairie Director Genopole Entreprises Genopole Vice President GenScript Corporation CEO Gevo, Inc Chief Commercial Officer GFBiochemicals CEO Ginkgo Bioworks Head of Business Development Ginkgo Bioworks Chief Operating Officer Global Bioenergies CEO Global Bioenergies CEO Glucan Biorenewables LLC Trade Relations Officer Government of Alberta Fibre & Composites Specialist Government of Manitoba, Canada Partner, Patent Agent Gowling Lafleur Henderson LLP Business Development VP GranBio Economic Development Director Greater Fort Dodge Growth Alliance President Green Biologics Global VP Business Development Green Biologics President Green Investment Group VP of Canadian Operations Green Investment Group Vice President Business Development Greenfield Specialty Alcohols President Greenius VP Business Development Greenyug LLC CEO Greenyug, LLC Senior Vice President GS Caltex President GSR Solutions Chief Business Officer Heliae CEO Heurisko GmbH Trade Commissioner High Commission of Canada To the UK Partner Husch Blackwell Senior Advisor iBIO Deputy Managing Director IFP ENERGIES NOUVELLES Commercial Development Manager IGPC Ethanol Inc. Vice President, Operations Illinois Biotechnology Industry Organization Manager Life Sciences & Advanced Technologies Illinois Department of Commerce & Economic Opportunity Prof. of Chemical Engineering Illinois Institute of Technology CEO Industrial
Load more

Recommended publications
  • A Performance Management Framework for State and Local Government: from Measurement and Reporting to Management and Improving
    40641 body E.qxp:Performance Management Commission 5/25/10 3:25 PM Page 1 A Performance Management Framework for State and Local Government: From Measurement and Reporting to Management and Improving National Performance Management Advisory Commission 40641 body E.qxp:Performance Management Commission 5/25/10 3:25 PM Page 3 A Performance Management Framework for State and Local Government: From Measurement and Reporting to Management and Improving National Performance Management Advisory Commission 40641 body E.qxp:Performance Management Commission 5/25/10 3:25 PM Page 4 Copyright 2010 by the National Performance Management Advisory Commission 203 North LaSalle Street, Suite 2700 Chicago, Illinois 60601 www.pmcommission.org All rights reserved. The National Performance Management Advisory Commission encourages governments to use and reproduce this material freely in govern- ment documents. Any other use of this material is prohibited without written permission from the publisher. Library of Congress Control Number: 2010928402 ISBN 978-0-89125-303-7 Printed in the United States of America. This publication is written with the understanding that neither the publisher nor the authors are engaged in rendering legal advice. If legal or other expert assistance is required, the reader should solicit the services of a competent professional in the field. The publisher and the authors specifically disclaim any personal liability for loss or risk incurred as a consequence of the use and application, either directly or indirectly, of any advice or
    [Show full text]
  • Science Committee
    SCIENCE COMMITTEE TERMS OF REFERENCE (Approved by the Board on 19 December 2016) (Established from 1 January 2017. Last updated on 6 May 2021) Role The Committee supports the Board in its understanding of the key strategic themes, upon which the Company’s R&D strategy is based, and of any external transactions, by performing in depth reviews of the underlying scientific assumptions to give the Board technical assurance. It also undertakes more in depth risk oversight of R&D related risks. Membership Chairman Dr Jesse Goodman Members Charles Bancroft Dr Laurie Glimcher Generally in Company Chairman attendance Chief Executive Officer (“CEO”) at each meeting: Chief Scientific Officer and President R&D (“CSO”) President, Global Vaccines In attendance as Independent senior external scientific adviser(s) as required: Chief Financial Officer Chief Medical Officer SVP, Head of Audit & Assurance SVP, Global Ethics & Compliance Other Company executives Secretary Company Secretary Constitution 1. The Board has established a Committee of the Board known as the Science Committee (the "Committee"). Membership 2. The Committee shall comprise a minimum of three Non-Executive Directors of the Company appointed by the Board. 3. The Committee Chairman shall be a Non-Executive Director, designated as a Scientific and Medical Expert, appointed by the Board following receipt of a proposal from the Nominations 1 Science Committee Terms of Reference & Corporate Governance Committee. 4. The Committee Chairman, in collaboration with the CSO and CEO, shall review membership of the Committee annually, as part of the annual performance evaluation of the Committee. Quorum 5. The quorum shall be three members.
    [Show full text]
  • Associate Superintendent / Chief Business Officer
    Sequoia Union High School District Job Description Associate Superintendent / Chief Business Officer LEVEL: Senior Management SALARY RANGE: Competitive, Negotiable and Based On Experience JOB SUMMARY: Under direction of the Superintendent, provides district wide leadership and supervises, plans, organizes, develops, and directs the Business Services Division, including the following departments: Fiscal Services, Accounting, Budget, Purchasing, Technology, Transportation, Nutrition, Grounds, Maintenance, Custodial, Operations, Energy, Nutrition, Risk Management, Construction and Planning including Bond Management Oversight; supervise and train management level division staff, promote programs to students, staff and the general public, supervise and participate in the preparation, accounting and maintenance of all related financial records, statements, reports and cost studies; provides and maintains efficient and effective business services to all schools and departments in the District, and to do other related work as required. ESSENTIAL FUNCTIONS (include but not limited to) The Associate Superintendent / Chief Business Officer provides District-wide leadership and direction in the following areas: 1. Oversees all business and administrative services programs, including all areas of development, implementation, and evaluation. 2. Represents the District in communicating and collaborating with other school districts, public agencies and the general public as directed. 3. Assists the Superintendent in establishing long-range and strategic
    [Show full text]
  • Notice of Meeting for the Eighteenth Annual General Meeting (AGM) of Glaxosmithkline Plc
    GlaxoSmithKline plc Image HIV virus Notice of Annual General Meeting Thursday 3 May 2018 at 2.30pm This document is important and requires your immediate attention. If you are in any doubt as to what action you should take, you should consult your stockbroker, bank manager, solicitor, accountant or other independent professional adviser immediately. If you have sold or otherwise transferred all of your shares, please pass this document, together with the accompanying documents, to the purchaser or transferee, or to the person who arranged the sale or transfer so they can pass these documents to the person who now holds the shares. 2 29 March 2018 To the holders of the company’s Ordinary Shares and American Depositary Shares. Dear Shareholder, Annual General Meeting 2018 I am pleased to enclose the Notice of Meeting for the eighteenth Annual General Meeting (AGM) of GlaxoSmithKline plc. The AGM will be held on Thursday 3 May 2018 at 2.30pm at the QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE. If you will not be attending, you may appoint a proxy by completing and returning the enclosed proxy form. Alternatively, you may appoint a proxy electronically via www.shareview.co.uk, www.sharevote.co.uk or, if you hold your shares in CREST, via the CREST system. Notice of your appointment of a proxy should reach the company’s registrar, Equiniti, by 2.30pm on Tuesday 1 May 2018. If you hold your shares through a nominee service, please contact the nominee service provider regarding the process for appointing a proxy. Included in the business of the AGM are resolutions to receive and adopt the Directors’ Report and the Financial Statements for 2017, to approve the Annual report on remuneration for the year ended 31 December 2017 and to confirm the appointment of Deloitte LLP as the company’s auditors.
    [Show full text]
  • Executive Director Supervises: Development Manager Status
    Position Title: Development Director Reports to: Executive Director Supervises: Development Manager Status: Full-time exempt Starting Salary: $68,000 - $75,000, DOE, with generous benefits package Closing Date: Open until filled; review of applications will begin on August 31, 2020 Summary of Position: As the Development Director of the Gallatin Valley Land Trust (GVLT), you will lead the organization’s philanthropy program, helping to fuel and accelerate GVLT’s work to conserve the Valley’s open lands and expand the Main Street to the Mountains trail system. The ideal candidate will be an eager collaborator with our Board of Directors and staff and will be able to articulate a philanthropic vision to ensure sufficient resources for our strategic goals. The ideal candidate will work closely with GVLT’s community of dedicated supporters to inspire and mobilize investments in organizational capacity as well as trail and conservation projects. The ideal candidate will be both a thoughtful manager and eager team member of the development staff, fostering high morale and a strong esprit de corps. Adaptable, accessible, creative, and enthusiastic, you will work closely with the Executive Director and the Leadership Team to provide strategic direction and both long and short range planning to identify, cultivate, solicit, and steward existing donors and prospects. In addition to being responsible for the philanthropy program, the Development Director will work specifically with GVLT’s Conservators Circle donors ($1,000 and above). The ideal candidate will come with the requisite skills and knowledge to grow and nurture the planned giving program as well as manage and empower the Board Development Committee to support GVLT’s fundraising efforts.
    [Show full text]
  • Resolution Notice (PDF: 67KB)
    NOTICE: This is a translation of a notice in Japanese issued on June 23, 2017 and is made solely for the convenience of foreign shareholders. In the case of any discrepancy between the translation and the Japanese original, the latter shall prevail. Securities code: 4536 June 23, 2017 RESOLUTION NOTICE OF THE 105TH ANNUAL GENERAL MEETING OF SHAREHOLDERS OF SANTEN PHARMACEUTICAL CO., LTD. Dear Shareholder: We hereby inform you of the reports and the resolutions that were made, as set forth below, in the 105th Annual General Meeting of Shareholders of the Company that was held today. Reports: 1. Reports on the Business Report, Consolidated Financial Statements and Financial Statements for the 105th Business Term (April 1, 2016 to March 31, 2017) 2. Reports on the Audit Reports by the Accounting Auditors and the Board of Corporate Auditors on the Consolidated Financial Statements for the 105th Business Term (April 1, 2016 to March 31, 2017) As regards the items set forth above, the contents thereof were reported. Resolved Items: Proposal No. 1: Appropriation of Surplus As regards this item, the term-end dividends of profits were resolved to be JPY 13 per share as per the original proposal. Consequently, the total dividends for the annual business term, including the interim dividends previously distributed are JPY 26 per share. Proposal No. 2: Appointment of Seven (7) Directors As regards this item, Akira Kurokawa, Takeshi Ito, Akihiro Tsujimura, Shigeo Taniuchi, Takayuki Katayama, Kanoko Oishi and Yutaro Shintaku were appointed as per the original proposal; each of them assumed their respective offices. Takayuki Katayama, Kanoko Oishi and Yutaro Shintaku are Outside Directors.
    [Show full text]
  • ETF Portfolios Summit 2016 Wednesday 11Th May 2016 Hosted by ETF Strategy & London Stock Exchange
    ETF Portfolios Summit 2016 Wednesday 11th May 2016 Hosted by ETF Strategy & London Stock Exchange 08.25 – 08.55 Registration and Networking breakfast 08.55 – 09.00 Welcome introduction Pietro Poletto, Head of ETF & Fixed Income Markets, London Stock Exchange 09.00 – 09.30 UBS Andrew Walsh, Executive Director, Head UBS ETF Essentials of passive sustainable investing UK & Ireland KEYNOTE - Growing importance of sustainable investing - Sustainable indexed investing Florian Cisana, Director, UBS ETF UK & Ireland - Implementation aspects - Portfolio applications: Example of decarbonized exposure 09.30 – 09.50 First Trust Eric Anderson, Vice President & Senior Portfolio 'Smarter' portfolio construction with smart beta ETFs Manager, First Trust - Introduction to fundamentally weighted AlphaDEX methodology - Constructing portfolios using AlphaDEX building blocks - Exploring the benefits of country rotation strategies 09.50 - 10.10 WisdomTree Europe Viktor Nossek, Director of Research, WisdomTree ETF strategies for geopolitical uncertainty and sub-zero rate risks Europe - Major macro risks in 2016 - "Brexit": Lessons from "Grexit" in 2015 and "Scottit" in 2014 - Sub-zero Rates: Distortions in credit markets and implications for equities - EM Producer Deleveraging: Yield premium in equities 10.10 - 10.30 Lyxor Chanchal Samadder, Head of UK & Ireland ETF Building an Emerging Markets allocation using ETFs Sales, Lyxor - Are Emerging Markets set for a comeback in 2016? - Navigating high levels of dispersion among Emerging Markets: the end of acronym
    [Show full text]
  • Revised 3/3/19 JOB TITLE: Development Director REPORTS
    JOB TITLE: Development Director REPORTS TO: Executive Director STATUS: Exempt, Full-time POSITION SUMMARY: The Development Director is responsible for overseeing the development team to meet the funding, community engagement, and volunteer goals that exceed the support needs of Billings Leadership Foundation (BLF) and the partners we support. The Development Director will work to increase and expand annual giving, implement a well- rounded image and moves management program, secure and enhance foundation giving, maintain grant reporting, develop and write materials in brochures, presentations, appeals and newsletters and work with direct-mail vendors to ensure proper messaging and drive income to exceed the revenue goals of BLF. In addition to managing a portfolio of individual donors for cultivation and solicitation, the Development Director is responsible for maintaining relationships with current community partners, foundations, and corporations. The Development Director will work with staff from the various programs we support to accurately portray program testimonies to our donors. BLF is a donor-centered, community driven organization and the Development Director ensures organizational compliance with ethical practices in fund solicitation as defined by the Association of Fundraising Professionals. The Development Director will oversee the development department team (and contractors) including those who write grants and develop publicity materials- to ensure accurate and effective messaging is delivered, those who engage volunteers-
    [Show full text]
  • As of July 22, 2021 TUESDAY, JULY 27
    As of July 22, 2021 TUESDAY, JULY 27 10:00-10:30am WELLNESS BREAK Yoga in the NACUBO Booth 11:00–11:15am Welcome Susan Whealler Johnston, President and CEO, NACUBO Megan Strand, Host and Producer CBO Speaks 11:15am–12:15pm Opening Session: The Hidden Brain Shankar Vedantam, NPR Social Science Correspondent and Host of Hidden Brain Robert Moore, Senior Vice President for Finance and Administration, Colorado College NPR science correspondent Shankar Vedantam offers unique insights into how our unconscious biases — what he calls the hidden brain — affect the decisions we make both personally and as groups and organizations. He bases these insights on data, not on psychological theories of the subconscious. Few speakers bring such a trove of breakthroughs in social science research to their audiences’ concerns. The Hidden Brain. Like a puppeteer behind a curtain, the hidden brain shapes our behavior, our choices, and the course of our relationships. But unconscious biases don’t just live in our individual brains; they also influence the success or failure of our organizations. In his presentations, as in his book The Hidden Brain: How Our Unconscious Minds Elect Presidents, Control Markets, Wage Wars, and Save Our Lives, Vedantam reveals these unconscious patterns and he lays out ways in which we can avoid the mistakes they often cause. CPE Category: Personal Development 12:15-1:30pm EXPO HALL 12:30-1:00pm WELLNESS BREAK Meditation in the NACUBO Booth 1:30-2:30pm CONCURRENT SESSIONS Community College Business Officers Roundtable Melissa Beardmore, vice president for learning resources management, Anne Arundel Community College Liz Clark, vice president, policy and research, NACUBO Randy Roberson, vice president, leadership development, NACUBO As higher education moves beyond the pandemic, what do the next few years hold for community colleges? Turn on your camera and connect with community college colleagues to discuss post-pandemic business and financial management issues.
    [Show full text]
  • Press Release Climeco Promotes Derek Six to Chief Business Officer
    Press Release FOR IMMEDIATE DISTRIBUTION CONTACT Nancy Marshall, Marketing Director 864-266-1210 or [email protected] ClimeCo Promotes Derek Six to Chief Business Officer August 8, 2018 (BOYERTOWN, PA) – ClimeCo is pleased to announce the promotion of Derek Six as our new Chief Business Officer. ClimeCo has grown exponentially in the last three years by adding professionals with incredible talent and by expanding into new markets. Mr. Six’s new role as Chief Business Officer will combine the traditional roles of Chief Operating Officer and Chief Financial Officer. “Derek has demonstrated incredible leadership in these areas historically,” says Bill Flederbach, President & CEO of ClimeCo. “He is someone who has the skills, focus, and drive to elevate ClimeCo’s growth for the future.” Mr. Six joined ClimeCo in 2015 after serving as the CEO of Environmental Credit Corp and has worked in the environmental markets since 2006. He is deeply involved in Cap and Trade policy and Offset policy — including co-founding the Carbon Offset Provider’s Coalition (COPC) and participating in the Compliance Offset Developer’s Association (CODA), the Verified Emission Reduction Association (VERA), the Climate Action Reserve ODS workgroup, and many other policy and trade associations. “I am honored to be ClimeCo’s new Chief Business Officer as we position ourselves for some amazing growth,” says Derek Six. “We have seen some truly monumental shifts in the last couple of years and I am excited about our future.” ClimeCo is a leader in the management and development of environmental commodities. We combine unrivaled commodity market expertise with engineering and environmental assessment, permitting and transaction structuring to help clients maximize their environmental assets and minimize their regulatory costs.
    [Show full text]
  • Development Director
    Development Director Mission: Cultivating environmentally sound, economically viable, community-focused farms and food systems Position overview: We’re seeking a Development Director to ignite enthusiasm to financially support Pasa’s mission; ensure that donors are appropriately engaged with our work; and identify, cultivate, and solicit current and prospective contributors to increase annual giving. The development director will work closely with the Executive Director, Operations Director, Communications staff, and Board of Directors in designing, coordinating, and implementing development programs, including giving from individuals, corporations, foundations, and other private support. The development director will foster continuity across programs and streamline processes for soliciting, stewarding, and reporting on all donor activities. This position can either be primarily remote or based out of Pasa’s office in Harrisburg, Pennsylvania. There will be some in-office workdays and monthly in-person all-staff meetings in Harrisburg. This is a highly flexible, dynamic position that requires regular regional travel for funder relationship building, as well as networking. All employees are required to attend our annual Sustainable Agriculture Conference, which takes place each February in Lancaster, Pennsylvania. Meetings and travel will adhere to COVID-19 safety protocols. Employee must comply with Pasa’s remote employee policies. Key responsibilities ● With support from the Executive Director and Operations Director, develop an annual
    [Show full text]
  • Report of the Board of Directors on the Proposed Resolutions Submitted 4 to the Combined Shareholders’ Meeting of 30 May 2018
    REPORT OF THE BOARD OF DIRECTORS ON THE PROPOSED RESOLUTIONS SUBMITTED 4 TO THE COMBINED SHAREHOLDERS’ MEETING OF 30 MAY 2018 REPORT OF THE BOARD OF DIRECTORS ON THE PROPOSED RESOLUTIONS SUBMITTED TO THE COMBINED SHAREHOLDERS’ MEETING OF 30 MAY 2018 The Board of Directors convenes the Shareholders of the Allocation: Company to the Combined Shareholders’ Meeting to be • No allocation to the legal reserve – held on 30 May 2018, in order to report on the Company’s (the amount being beyond 10% of the share capital) operations during the financial year closed 31 December • Dividends €83,782,308.00 2017 and submit the following proposed resolutions to their approval: • Retained earnings €57,715,274.70 The ex-dividend date for the total gross dividend of €1.00 due Q A p p r ova l o f t h e 2 0 17 a n n u a l fi n a n c i a l s t a t e m e n t s for each share would be 4 June 2018 and its payment date st rd and allocation of results (1 to 3 ordinary 6 June 2018. resolutions) In the event of a change in the number of shares carrying a The first items on the agenda relate to the approval of right to a dividend in comparison with the 83,782,308 shares the annual financial statements (first resolution) and the comprising the share capital on 14 February 2018, the overall consolidated financial statements (second resolution). amount of dividends would be accordingly adjusted and Ipsen SA’s annual financial statements for the year closed the amount allocated to the retained earnings would be 31 December 2017 show a loss of €17,369,249.12.
    [Show full text]